Digital twin simulations with a micro-multiphysics agent-based model reveal key drivers of bone loss after denosumab discontinuation. [PDF]
Ledoux C +4 more
europepmc +1 more source
The regulation of the sclerostin gene and the catabolic effects of sclerostin protein on bone.
Amugoda Kankanange Asiri R. Wijenayaka
openalex +1 more source
Sclerostin Antibody Augments the Anabolic Bone Formation Response in a Mouse Model of Mechanical Tibial Loading [PDF]
Alyson Morse +5 more
openalex +1 more source
Collagen glycosylation, hip structural analysis, and trabecular bone score in adolescents with type 1 diabetes: a cross-sectional study. [PDF]
Krishnan S +7 more
europepmc +1 more source
Sclerostin Antibody Preserves the Morphology and Structure of Osteocytes and Blocks the Severe Skeletal Deterioration After Motor-Complete Spinal Cord Injury in Rats [PDF]
Weiping Qin +14 more
openalex +1 more source
Osteoporosis After Menopause and After Drug Therapy: The Molecular Mechanism of Bone Loss and Its Treatment. [PDF]
Lee KI, Chen JH, Chen KH.
europepmc +1 more source
Sclerostin-silenced human umbilical cord mesenchymal stem cells ameliorate bone metabolism in steroid-induced femoral head necrosis. [PDF]
Lv H +7 more
europepmc +1 more source
Novel use of bisphosphonates to improve surgical outcomes in experimental bone tuberculosis. [PDF]
Petukhova VV +8 more
europepmc +1 more source
Lipid Nanoparticle Delivery of siRNA to Osteocytes Leads to Effective Silencing of SOST and Inhibition of Sclerostin In Vivo [PDF]
Genc Basha +6 more
openalex +1 more source

